Vanda Pharmaceuticals VNDA Earnings Call Transcripts

NASDAQ VNDA
$4.08 -0.01 (-0.24%)
At close: Nov 10, 2026 · 4:00 PM EST
10 earnings calls on file for Vanda Pharmaceuticals, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Vanda Pharmaceuticals Q3 2026 Earnings Call

Oct 28, 2026 7,840 words · 34 min read
  • Kevin MoranChief Financial Officer
  • Dr. Mihael PolymeropoulosPresident, Chief Executive Officer, and Chairman of the Board
  • Daniel McGuireGeneral Counsel
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Vanda Pharmaceuticals Earnings Call Transcripts

Calls10
LatestOct 28, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 10 Vanda Pharmaceuticals transcripts Register to get access to Vanda Pharmaceuticals’s earnings call transcripts.